AISLABIE BLOODSTOCK LIMITED

Company Registration Number:
06314676 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2021

Period of accounts

Start date: 01 January 2021

End date: 31 December 2021

AISLABIE BLOODSTOCK LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2021

Balance sheet
Notes

AISLABIE BLOODSTOCK LIMITED

Balance sheet

As at 31 December 2021


Notes

2021

2020


£

£
Fixed assets
Tangible assets: 3 1,515,563 1,561,183
Total fixed assets: 1,515,563 1,561,183
Current assets
Stocks: 1,853,500 2,079,500
Debtors:   236,300 547,514
Cash at bank and in hand: 121,536 8,139
Total current assets: 2,211,336 2,635,153
Creditors: amounts falling due within one year: 4 (14,415,533) (14,166,135)
Net current assets (liabilities): (12,204,197) (11,530,982)
Total assets less current liabilities: (10,688,634) (9,969,799)
Total net assets (liabilities): (10,688,634) (9,969,799)
Capital and reserves
Called up share capital: 100 100
Profit and loss account: (10,688,734) (9,969,899)
Shareholders funds: (10,688,634) (9,969,799)

The notes form part of these financial statements

AISLABIE BLOODSTOCK LIMITED

Balance sheet statements

For the year ending 31 December 2021 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 13 August 2022
and signed on behalf of the board by:

Name: F Nass
Status: Director

The notes form part of these financial statements

AISLABIE BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2021

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

AISLABIE BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2021

2. Employees

2021 2020
Average number of employees during the period 11 12

AISLABIE BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2021

3. Tangible Assets

Total
Cost £
At 01 January 2021 2,155,057
Additions 32,653
Disposals (122,643)
At 31 December 2021 2,065,067
Depreciation
At 01 January 2021 593,874
Charge for year 78,273
On disposals (122,643)
At 31 December 2021 549,504
Net book value
At 31 December 2021 1,515,563
At 31 December 2020 1,561,183

AISLABIE BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2021

4. Creditors: amounts falling due within one year note

Trade Creditors 488225Other Creditors 7097Loans 13879844VAT 40367